Clinical Trials
32 trialsCancer and Blood Pressure Management, CARISMA Study
Eastern Cooperative Oncology Group
AH-HA
Wake Forest University Health Sciences
PCT
Abramson Cancer Center at Penn Medicine
ONE TEAM
Duke University
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
TACkLE
University Medical Center Groningen
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Western University
CV CARE: CardioVascular Care in PC Patients
Dana-Farber Cancer Institute
ALLSTAR
Abramson Cancer Center at Penn Medicine
MoveStrong
University of Waterloo
EMPOWER
Future Genetics Limited
RADICALPC
McMaster University
Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
PURE
Population Health Research Institute
CAT_PB
Lebanese University
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Audubon Bioscience
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
MMetdMH
Royal College of Surgeons, Ireland
PACEinMM-QC
Université de Sherbrooke
SCHS
Duke-NUS Graduate Medical School
SOROCOV
Butantan Institute
Cardiovascular Events in GnRH Agonist vs. Antagonist
Rabin Medical Center
INTELLECT
NHS Greater Glasgow and Clyde
VECTOR
NHS Greater Glasgow and Clyde
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Rabin Medical Center
PHS II
Brigham and Women's Hospital
Understanding the Value of Community Vital Signs in Primary Care
Virginia Commonwealth University
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
HIITTS
University of Alberta
REMIND
Brigham and Women's Hospital
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
Apeiron Biologics